Cross-border pharmacy services: EU generic drug mobility

Imagine you’re on vacation in southern France and your asthma inhaler runs out. Back home, you’ve been using the same generic version for years-cheap, effective, and covered by your insurance. But here? The pharmacy doesn’t recognize your prescription. It’s printed on paper. No barcode. No digital trace. You’re stuck. This isn’t a rare situation. It’s happening every day across the EU, even though the system was designed to make this exact thing easier.

How the EU’s cross-border pharmacy system actually works

The European Union built a digital bridge for prescriptions. It’s called eHDSI, part of the MyHealth@EU platform. Since 2011, EU law has guaranteed that if you’re legally prescribed a medicine at home, you can get it filled in another EU country. No extra paperwork. No need to see a new doctor. Just show up at a pharmacy with your ePrescription, and they pull it up securely through your home country’s system.

Right now, 27 EU and EEA countries are connected. That means if you live in Poland and need your blood pressure meds while visiting Spain, your doctor’s digital prescription follows you. The pharmacy in Madrid accesses it through the secure EU network. No physical paper. No translation headaches. The system even sends a Patient Summary-your allergies, current meds, and past conditions-in the local language.

But here’s the catch: it only works if both sides are actually using it. Germany, France, Austria, and the Netherlands have fully integrated. But in countries like Romania or Bulgaria, the system exists on paper, not in practice. Pharmacists there might not have the software. Or they might not know how to use it. And if they don’t, you’re back to square one.

Why some prescriptions still get rejected

One of the biggest problems isn’t technology-it’s rules. Take Ireland. If you show up with a prescription from a UK telehealth service, the pharmacist is legally required to refuse it. Even if the medicine is identical, the prescriber wasn’t registered in the EU. The same goes for prescriptions from non-EU countries. The EU doesn’t recognize them. Period.

Even within the EU, differences cause confusion. Italy switched from the old ‘bollino’ sticker on prescriptions to GS1 DataMatrix codes in February 2025. That’s a scannable barcode. But if you’re from Slovenia and your prescription still has the old sticker, the Italian pharmacy might not be able to read it. They’ll ask you to go back to your doctor. And that’s not just inconvenient-it’s dangerous if you’re running out of medicine.

Pharmacists are stuck in the middle. They’re expected to verify prescriptions from 27 different systems, each with different rules, formats, and security protocols. A 2025 study found pharmacists need about 40 hours of training just to handle cross-border prescriptions properly. Most don’t get it. So they play it safe: reject anything that looks unfamiliar.

The gap between policy and reality

Only 8 out of 27 EU countries have clear rules for how pharmacists should behave in online or cross-border settings. That means in half the bloc, there’s no official guidance on what to do if a patient shows up with a prescription from another country. Do they call the home country? Do they check the prescriber’s license? Do they even know how?

And then there’s awareness. A 2025 Eurobarometer survey found only 38% of EU citizens even know they have the right to fill prescriptions abroad. That number jumps to 72% in places like the Dutch-German border, where cross-border healthcare has been common for decades. But in rural areas of Portugal or Hungary? Most people don’t know the system exists.

It’s not just about access-it’s about trust. People are afraid. They worry their medical data is being shared without consent. The system requires explicit permission through national portals like island.is in Iceland or eID in Germany. But the process is clunky. You might need to log in twice, set time limits, and approve each country individually. If you’re 70 and not tech-savvy? You give up.

Who’s benefiting-and who’s being left behind

The real winners are people in border regions. In the Nordics, where Sweden and Finland share a long border, pharmacies often stock identical generic drugs from both countries. Patients cross for cheaper insulin or cheaper asthma inhalers. In the Netherlands, pharmacies near the German border have bilingual staff and dedicated EU prescription lanes. A 2025 survey found 78% of patients there successfully filled cross-border prescriptions.

But outside those zones? It’s a mess. Travelers report being turned away for medications they’ve used for years. One Reddit user from Lithuania described flying to Portugal and being denied her epilepsy medication because the pharmacist didn’t recognize the German prescription format. Another from Ireland spent three days in Spain trying to refill her diabetes meds-only to be told she needed a new prescription from a Spanish doctor.

And then there’s the shortage problem. The EU’s new Critical Medicines Act, launched in 2025, forces drug makers to report supply issues across borders. That’s good in theory. But in practice, it’s still patchy. If a generic drug runs out in Belgium, the system doesn’t automatically reroute stock from Poland. Pharmacies still have to call each other. Fax requests. Wait days. And patients suffer.

What’s changing in 2025 and beyond

There are signs of progress. Iceland is set to fully join the EU health data network by August 31, 2025. That means patients from Iceland will soon be able to fill prescriptions anywhere in the EU, and vice versa. Italy’s switch to scannable codes is making prescriptions more reliable. The European Commission is tightening rules under Regulation (EU) 2025/327, giving itself power to shut down non-compliant systems.

The European Association of E-Pharmacies (EAEP) is pushing for five big changes: full pan-European prescription delivery, access to electronic health records, flexible supply chains to fix shortages, fair reimbursement for digital services, and expanded telepharmacy for rural areas. Their 2025 Action Plan says digital pharmacy services cut medication errors by 22% and improve chronic disease adherence by 17%. Those are real numbers.

But the biggest hurdle isn’t tech-it’s politics. Each country still controls its own pharmacy rules, pricing, and reimbursement. A drug that costs €5 in Poland might cost €22 in Denmark. Who pays? The patient? The home country? The destination country? No one has agreed.

What you need to do to use cross-border pharmacy services

If you’re planning to travel and need your meds:

• Ask your doctor for an ePrescription-not a paper one. Make sure it’s issued through your national digital health system.
• Confirm your home country has activated ePrescription export. Germany, France, Austria, the Netherlands, and Estonia have. Others? Not always.
• Check if your medicine is available in the country you’re visiting. Generics have different names. A drug called “Metformin” in Germany might be sold as “Glucophage” in Italy.
• Bring your European Health Insurance Card (EHIC). It doesn’t cover the cost, but it proves you’re covered under EU health rules.
• Know your rights. Under Directive 2011/24/EU, you can’t be denied a prescription just because it’s from another EU country.

And if you’re a pharmacist? Start training. Learn how to read ePrescriptions. Understand the Patient Summary. Know which countries are connected. Your role is now part of a cross-border health network-not just a local pharmacy.

The future isn’t automatic-it’s negotiable

The EU has the tech. It has the laws. It has the data. But it doesn’t have the will to make it work everywhere. Right now, cross-border pharmacy services are like a highway with toll booths in every country. Some booths are open. Others are locked. Some don’t even have signs.

By 2030, IQVIA predicts the system could cut medication access gaps by 35%. But only if countries stop treating this as a national issue and start treating it like a shared health system. Right now, patients are paying the price for bureaucracy.